175 related articles for article (PubMed ID: 19927001)
1. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.
Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001
[TBL] [Abstract][Full Text] [Related]
2. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
4. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
6. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
[TBL] [Abstract][Full Text] [Related]
7. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
Malickova K; Lukas M; Donoval R; Sandova P; Janatkova I
Clin Lab; 2006; 52(11-12):631-8. PubMed ID: 17175895
[TBL] [Abstract][Full Text] [Related]
8. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Bansi DS; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
12. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
15. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease serology in Asia and the West.
Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
[TBL] [Abstract][Full Text] [Related]
18. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?
Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M
Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186
[TBL] [Abstract][Full Text] [Related]
19. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
